Clinic photos coming soon
About Biostar Stem Cell Research Institute
Biostar Stem Cell Research Institute, a leading South Korean biotechnology company, stands at the forefront of regenerative medicine, pioneering innovative stem cell therapies to address a range of debilitating conditions. Founded on a commitment to scientific excellence and patient-centric care, Biostar has established a global reputation for its cutting-edge research and development in the field of adult stem cell technology. The institute's mission is to unlock the vast therapeutic potential of stem cells, offering new hope to patients with limited treatment options. Biostar's research focuses on autologous stem cells, which are derived from the patient's own tissues, minimizing the risk of rejection and ethical concerns. This patient-specific approach ensures the highest standards of safety and efficacy. Biostar's history is marked by a series of groundbreaking achievements. The institute has been instrumental in developing and commercializing stem cell therapies for a variety of diseases. A key milestone in Biostar's journey was the development of 'JointStem,' a revolutionary treatment for degenerative arthritis. This therapy utilizes a patient's own fat-derived stem cells to regenerate damaged cartilage, offering a non-invasive alternative to surgery. Another significant breakthrough is 'VascoStem,' a therapy for Buerger's disease, a rare and severe condition that affects blood vessels. Biostar's commitment to innovation is further demonstrated by its ongoing clinical trials for 'AstroStem,' a promising treatment for Alzheimer's disease, and its research into therapies for Parkinson's disease and other neurological disorders. These efforts underscore Biostar's dedication to tackling some of the most challenging medical conditions of our time. The institute's specialties are diverse, reflecting its comprehensive approach to regenerative medicine. Biostar's core expertise lies in the isolation, cultivation, and storage of adult stem cells, particularly mesenchymal stem cells derived from adipose tissue and cord blood. The institute has developed proprietary technologies to ensure the quality and viability of these cells, adhering to the highest international standards.
Biostar's treatment portfolio includes therapies for orthopedic conditions, autoimmune diseases, and neurological disorders. The institute's approach to treatment is holistic and personalized. Each patient undergoes a thorough evaluation to determine their suitability for stem cell therapy. A customized treatment plan is then developed to address their specific needs. The therapy itself involves the collection of the patient's own stem cells, which are then processed and reintroduced into the body to promote healing and regeneration. Biostar's facilities are state-of-the-art, reflecting its commitment to quality and safety. The institute operates a world-class research and development center in Seoul, South Korea, equipped with the latest technologies for cell processing and analysis. This facility adheres to strict Good Manufacturing Practice (GMP) guidelines, ensuring the purity and potency of its stem cell products. In addition to its research facilities, Biostar has a network of affiliated clinics and hospitals in South Korea and Japan, where patients can receive treatment. These clinics are staffed by a team of experienced doctors and medical professionals who are dedicated to providing the highest level of care. The patient experience at Biostar is characterized by compassion, professionalism, and a commitment to achieving the best possible outcomes. Patients receive comprehensive support throughout their treatment journey, from initial consultation to post-therapy follow-up. Biostar's influence extends beyond its clinical activities. The institute is actively involved in public education and awareness campaigns to promote a better understanding of stem cell technology. Biostar also collaborates with leading academic institutions and research organizations around the world to advance the field of regenerative medicine. Through its pioneering research, innovative therapies, and unwavering commitment to patient care, Biostar Stem Cell Research Institute is shaping the future of medicine and offering new hope to patients worldwide.
20+
Years Experience
Clinic Information
Address
305, Lotte IT Castle Building #2, 550-1, Gasan-dong, Geumcheon-gu, Seoul, South Korea
Phone
+82-2-858-8021Website
www.stemcellbio.comHours
Not available
Languages
Korean, English
Accreditations
CGMP, MFDS
Payment Options
Not available
Treatments Offered
Medical Team
Dr. Jeong-chan Ra
D.V.M., PhD
Founder and Chairman
Frequently Asked Questions
Biostar primarily utilizes autologous adult stem cells, which are harvested from the patient's own body, typically from adipose (fat) tissue. This approach minimizes the risk of immune rejection and avoids the ethical concerns associated with embryonic stem cells.
Biostar has developed and is researching a range of therapies for various conditions, including degenerative arthritis (JointStem), Buerger's disease (VascoStem), Alzheimer's disease (AstroStem), and Parkinson's disease. They also offer stem cell banking services.
Biostar places a strong emphasis on safety. By using a patient's own stem cells, the risk of adverse reactions is significantly reduced. The institute also adheres to strict Good Manufacturing Practice (GMP) standards in its state-of-the-art facilities to ensure the quality and purity of its stem cell products.
The process typically begins with a comprehensive consultation and evaluation to determine a patient's eligibility. If deemed a suitable candidate, the patient's stem cells are collected, processed, and then administered back into the body, often through intravenous infusion or direct injection into the affected area.
Biostar is headquartered in South Korea and has a network of affiliated clinics and hospitals in both South Korea and Japan. Patients seeking treatment should contact Biostar directly to inquire about specific locations and availability.
Trust Score
32Get a Free Quote
By submitting, you agree to our privacy policy.